{"id":"NCT00051636","sponsor":"Novartis Pharmaceuticals","briefTitle":"Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period","officialTitle":"Randomized, Double-blind, Safety and Efficacy Trial With Intravenous Zoledronic Acid for the Treatment of Paget's Disease of Bone Using Risedronate as a Comparator, Including an Extended Observational Period","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-01","primaryCompletion":"2004-03","completion":"2011-04","firstPosted":"2003-01-15","resultsPosted":"2012-05-07","lastUpdate":"2012-05-15"},"enrollment":172,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Paget's Disease of Bone"],"interventions":[{"type":"DRUG","name":"Zoledronic Acid","otherNames":["Reclast, Aclasta"]},{"type":"DRUG","name":"Risedronate","otherNames":["Actonel"]},{"type":"DRUG","name":"Placebo to Risedronate","otherNames":[]},{"type":"DRUG","name":"Placebo to Zoledronic Acid","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Calcium and Vitamin D","otherNames":[]}],"arms":[{"label":"Zoledronic Acid and Placebo to Risedronate","type":"EXPERIMENTAL"},{"label":"Risedronate and Placebo to Zoledronic Acid","type":"ACTIVE_COMPARATOR"}],"summary":"The core study looked at the effect of Zoledronic Acid given once as an intravenous (i.v.) infusion compared to 60 days of oral Risedronate in patients with Paget's disease of bone. The effect was demonstrated in the reduction of serum alkaline phosphatase (SAP). The extended observation period included participants of the core study who responded to treatment.","primaryOutcome":{"measure":"Number of Patients Who Achieve Therapeutic Response at 6 Months.","timeFrame":"6 months","effectByArm":[{"arm":"Zoledronic Acid and Placebo to Risedronate","deltaMin":85,"sd":null},{"arm":"Risedronate and Placebo to Zoledronic Acid","deltaMin":60,"sd":null}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":34,"countries":["United States","Australia","Canada","New Zealand","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":89},"commonTop":["Arthralgia","Headache","Nausea","Nasopharyngitis","Pain in extremity"]}}